Related Experiment Video
Updated: Oct 21, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Patients' Risk Tolerance for Non-Dietary Therapies in Celiac Disease
Dennis De Leon Morilla1, Martin Ventoso1, Jessica Lebovits1
1Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, New York, New York.
Abstract:
Celiac disease (CD) is an autoimmune disorder mediated by an immune response to dietary gluten that affects the small intestine and leads to inflammation, malabsorption, and systemic consequences.1 The only established therapy is strict adherence to a gluten-free diet.2,3 Recently there has been growth in the development of novel non-dietary therapies for patients with CD,4 which are driven by dissatisfaction with the burden of the gluten-free diet.5,6.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Drugs for Treatment of Constipation-Predominant IBS
Chronic Kidney Disease III: Interprofessional Care
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...